Abiopharma

🔍 Mayer Bethany (Executive)

Company: BOX INC (BOX)

Report Date: 2026-06-25

Detailed Transactions and Holdings:

• Acquired 12,266 shares of Class A Common Stock (Direct)
  Date: 2026-06-25 | Code: A | equity_swap_involved: false | shares_owned_after: 21,288.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 1,325 shares of Class A Common Stock at $25.778 per share (Direct)
  Date: 2026-06-26 | Code: S | equity_swap_involved: false | shares_owned_after: 19,963.00 | transaction_form_type: 4 | Footnotes: F3, F4, F2
• Sold 2,735 shares of Class A Common Stock at $26.108 per share (Direct)
  Date: 2026-06-26 | Code: S | equity_swap_involved: false | shares_owned_after: 17,228.00 | transaction_form_type: 4 | Footnotes: F3, F5, F2
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-06-25 | Code: H | nature_of_ownership: See footnote | shares_owned_after: 64,993.00 | Footnotes: F6

Footnotes:

• F1: Represents an annual restricted stock unit ("RSU") award pursuant to the Issuer's Outside Director Compensation Policy. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement. 100% of the RSUs will vest on the earlier of (i) twelve months from date of grant (i.e. June 25, 2027) or (ii) the date of the Issuer's next annual meeting of stockholders.
• F2: Certain of these shares are represented by RSUs. Each RSU represents the Reporting Person's right to receive one share of Common Stock of the Issuer subject to the applicable vesting schedule and the Reporting Person's continuous service through each such date.
• F3: The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2025.
• F4: This sale price represents the weighted average sale price of the shares sold ranging from $25.00 to $25.96 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
• F5: This sale price represents the weighted average sale price of the shares sold ranging from $26.00 to $26.235 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
• F6: The shares are held of record by Bethany Mayer and Dale Jantzen, as Trustees of The Jantzen/Mayer Family 2002 Trust.